About: Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease; as well as DMX-652 for the treatment of acute kidney injury. The company is headquartered in Fitzroy, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.19 (-2.63%)
DXB ASX Dimerix Ltd
Dimerix Ltd share price
DXB price activity
Last Price
$0.190
Change (24hr)
-0.01 AUD (2.63%)
Volume
559.77K
Volume (4w avg)
-
Open
$0.19
Day Range
$0.18 - $0.19
Previous Close
$0.19
Last Trade
20 Nov, 5:10 am GMT+0
Delayed
20 Nov, 5:10 am GMT+0
DXB price performance
Delayed
20 Nov, 5:10 am GMT+0
DXB details
DXB Market Signals